More on BCYC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.2 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Bicycle Therapeutics Plc (NQ:BCYC)
Delayed: 3.96 -0.04 (1%)
Prev. Close $4.00  
Open$4.00 
52 Wk High$ 
52 Wk Low$ 
Day High$4.10 
Day Low$3.96 
P/E N/A  
EPS$ 
Volume401,758 

Friends, Peers and Foes (?): S1GE34, CATX, BCAX, BOLD, MAZE (more...)

Jun 3, 2026 04:32 AM Bicycle Therapeutics (BCYC) Reiterated at Market Outperform by Citizens
May 21, 2026 05:00 PM Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
May 20, 2026 02:42 PM Hippocratic AI Expands Life Sciences Leadership Team as Pharma and Medtech Demand for Voice AI Agents Accelerates
May 18, 2026 08:01 AM TRIANA Biomedicines appoints Mohan Bala as chief operating officer
May 18, 2026 08:00 AM TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board
May 7, 2026 05:00 AM William Blair Accelerates Investment in Biotech Equity Research and Equities Platform
May 1, 2026 07:11 AM Bicycle Therapeutics (BCYC) PT Lowered to $7 at Truist Securities
Apr 30, 2026 03:47 PM Bicycle Therapeutics (BCYC) PT Lowered to $12 at Jefferies
Apr 30, 2026 07:07 AM Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 20c
Apr 30, 2026 07:00 AM Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
View All Articles

Entities mentioned with BCYC

View All Entities